Biology of tree pollen allergens

Current Allergy and Asthma Reports

Volumn 4, Issue 5, 2004, Pages 384-390

  Mothes, Nadine ^a   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETULA POLLEN EXTRACT; CALCIUM BINDING PROTEIN; CROSS REACTING ANTIGEN; DNA VACCINE; FAGALES POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; POLLEN ANTIGEN; POLLEN EXTRACT; PROFILIN; RECOMBINANT ANTIGEN; RECOMBINANT DNA; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ALDER; ALLERGENICITY; ANGIOSPERM; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BETULACEAE; BIOLOGICAL MONITORING; BIRCH; CLINICAL TRIAL; CONIFER; CROSS REACTION; CUPRESSACEAE; DIAGNOSTIC VALUE; DRUG SAFETY; FAGACEAE; GYMNOSPERM; HUMAN; IMMUNODETECTION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOTHERAPY; NONHUMAN; OLEACEAE; PATIENT SELECTION; POLLEN ALLERGY; RADIOALLERGOSORBENT TEST; RECOMBINANT DNA TECHNOLOGY; REVIEW; SERODIAGNOSIS; SPECIES DIFFERENCE; TREE;

EID: 4544384896     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0089-y     Document Type: Review

References (72)

1. D'Amato G, Bonini S (eds): Pollenosis 2000: Global Approach. Naples, Italy: JGC Editions; 2001.
2. Kulig M, Klettke U, Wahn V, et al.: Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000, 106:832-839.
3. Niederberger V, Niggemann B, Kraft D, et al.: Evolution of IgM, IgE and IgG(1-4) antibody responses & early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur J Immunol 2002, 32:576-584.
4. Mittermann I, Swoboda I, Pierson E, et al.: Molecular cloning and characterization of profilin from tobacco (Nicotina tabacum): increased profilin expression during pollen maturation. Plant Mol Biol 1995, 27:137-146.
5. Ahlholm JU, Helander ML, Savolainen J: Genetic and environmental factors affecting the allergenicity of birch (Betula pubescens ssp. Czerepanovii [Orl.] Hamet-ahti) pollen. Clin Exp Allergy 1998, 28:1384-1388.
6. Kondo Y, Ipsen H, Lowenstein H, et al.: Comparison of concentrations of Cry j 1 and Cry j 2 in diploid and triploid Japanese cedar (Cryptomeria japonica) pollen extracts. Allergy 1997, 52:455-459.
7. Helander ML, Savolainen J, Ahlholm J: Effects of air pollution and other environmental factors on birch pollen allergens. Allergy 1997, 52:1207-1214.
8. Tashpulatov AS, Clement F, Akimcheva SA, et al.: A model system to study the environment-dependent expression of the Bet v 1a gene encoding the major birch pollen allergen. Int Arch Allergy Immunol 2004, 134:1-9.
9. Grote M, Vrtala S, Valenta R: Monitoring oftwo allergens, Bet v 1 and profilin, in dry and rehydrated birch pollen by immunogold electron microscopy and immunoblotting. J Histochem Cytochem 1993, 41:745-750.
10. Grote M, Valenta R, Reichelt R: Abortive pollen germination: a mechanism of allergen release in birch, alder, and hazel revealed by immunogold electron microscopy. J Allergy Clin Immunol 2003, 111:1017-1023.
11. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A: Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2 type pattern. J Immunol 1997, 158:2406-2413.
12. Knox RB, Suphioglu C, Taylor P, et al.: Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy 1997, 27:246-251.
13. Traidl-Hoffmann C, Kasche A, Menzel A, et al.: Impact of pollen on human health: more than allergen carriers? Int Arch Allergy Immunol 2003, 131:1-13.
14. Mothes N, Westritschnig K, Valenta R: Tree pollen allergens. In Allergens and Allergen Immunotherapy for Allergic Diseases, edn 3. Edited by Lockey RF, Bukantz SC, Bousquet J. New York: Marcel Dekker; 2004:165-184.
15. Rodriguez R, Villalba M, Monsalve RI, Batanero E: The spectrum of olive pollen allergens. Int Arch Allergy Immunol 2001, 125:15-19.
16. Schwietz IA, Goetz DW, Whisman BA, Reid MJ: Cross-reactivity among conifer pollens. Ann Allergy Asthma Immunol 2000, 84:87-93.
17. Wide L, Bennich H, Johnsson SG: Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967, 2:1105-1107.
18. Vik H, Florvaag E, Apold J, et al.: Comparative studies on tree pollen allergens, IV. Evaluation of two commercially available allergen extracts of alder (Alnus incana) and birch (Betuda verrucosa) pollen. Int Arch Allergy Appl Immunol 1982, 68:371-376.
19. Eriksson NE, Wihl JA, Arrendal H, Strandhede SO: Tree pollen allergy. III. Cross reactions based on results from skin prick tests and the RAST in hay fever patients: a multi-centre study. Allergy 1987, 42:205-214.
20. Yman L: Botanical Relations and Immunological Cross-reactions in Pollen Alleigy. Uppsala, Sweden: Pharmacia Diagnostics AB; 1978.
21. Moller C, Dreborg S: Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy 1986, 16:135-143.
22. Hemmens VJ, Baldo BA, Elsayed S, Bass D: Allergic response to birch and alder pollen allergens influenced by geographical location of allergic subjects. Int Arch Allergy Appl Immunol 1988, 87:321-328.
23. Petersen BN, Janniche H, Munch EP, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy, 1988, 43:353-362.
24. Wihl JA, Ipsen H, Petersen BN, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. II. Results of skin prick tests and nasal provocation tests from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazell. Allergy 1988, 43363-369.
25. Ipsen H, Schwartz. B, Wihl JA, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy. Allergy 1988, 43:370-377.
26. D'Amato C, Mullins J, Nolard N, et al.: City spore concentrations in the European Economic Community (EEC). VII. Oleaccae (Fraxinus, Ligustrum, Olea). Clin Allergy 1988, 18:541-547.
27. Yoo TJ, Spitz E, McGerity JL: Conifer pollen allergy: studies of immunogenicity and cross antigenicity of conifer pollens in rabbit and man. Ann Allergy 1975, 34:87-93.
28. Valenta R, Kraft D: Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 2001, 179:119-127.
29. Valenta R, Kraft D: From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002, 14:718-727.
30. Di Felice G, Barletta B, Tinghino R, Pini C: Cupressaceae pollinosis: identification, purification and cloning of relevant allergens. Int Arch Allergy Immunol 2001, 125:129.
31. Mothes N, Horak F, Valenta R: The transition from a botanical to a molecular classification in tree pollen allergy: Implications for diagnosis and therapy. Int Arch Allergy Immunol 2004, In press.
32. Breiteneder H, Pettenburger K, Bito A, et al.: The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989, 8:1935-1938.
33. Hoffmann-Sommergruber K: Plant allergens and pathogenesis-related proteins: What do they have in common? Int Arch Allergy Immunol 2000, 122:155-166.
34. Bufe A, Spangfort MD, Kahlert H, et al.: The major birch pollen allergen, Bet v 1, shows ribonuclease activity. Planta 1996, 199:413-415.
35. Markovic-Housley Z, Degano M, Lamba D, et al.: Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol 2003, 325:123-133.
36. Mogensen JE, Wimmer R, Larsen JN, et al.: The major birch allergen, Bet v 1, shows affinity for a broad spectrum of physiological ligands. J Biol Chem 2002, 277:23684-23592.
37. Elbaz M, Bremer J, Thibout E, et al.: A periwinkle PR-10 protein, CrPR-10a, has insecticide activity. Planta 2004, In press.
38. Valenta R, Duchene M, Vrtala S, et al.: Recombinant allergens for immunoblot diagnosis of tree pollen allergy. J Allergy Clin Immunol 1991, 88:889-894.
39. Menz G, Dolecek C, Schonheit-Kenn U, et al.: Serological and skin test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin Exp Allergy 1996, 26:50-60.
40. Niederberger V, Pauli G, Gronlund H, et al.: Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998, 102:579-591.
41. Valenta R, Breiteneder H, Pettenburger, et al.: Homology of the major birch-pollen allergen, Bet v 1, with the major pollen allergens of alder, hazel, and hornbeam at the nucleic acid level as determined by cross-hybridization. J Allergy Clin Immunol 1991, 87:977-982.
42. Breiteneder H, Ferreira F, Reikerstorfer A, et al.: cDNA cloning and expression in Escherichia coli of Aln g I, the major allergen in pollen of alder (Alnus glutinosa). J Allergy Clin Immunol 1992, 90:909-917.
43. Larsen JN, Stroman P, Ipsen H: PCR based cloning and sequencing of isogenes encoding the tree pollen major allergen Car b I from Carpinus betulus, hornbeam. Mol Immunol 1992, 29:703-711.
44. Vanek-Krebitz M, Hoffmann-Sommergruber K, Laimer da Camara Machado M, et al.: Cloning and sequencing of Mal d 1, the major allergen from apple (Mains domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun 1995, 214:538-551.
45. Ebner C, Hirschwelir R, Bauer L, et al.: Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995, 95:962-969.
46. Jensen-Jarolim E, Leitner A, Hirschwehr R, et al.: Characterization of allergens in Apiaceae spices: anise, fennel, coriander cumin. Clin Exp Allergy 1997, 27:1299-1306.
47. Hoffmann-Sommergruber K, O'Riordain G, Ahorn H, et al.: Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1. Clin Exp Allergy 1999, 29:840-847.
48. Scheurer S, Son DY, Boehm M, et al.: Cross-reactivity and epitope analysis of Pru av 1, the major cherry allergen. Mol Immunol 1999, 36:155-167.
49. Karamloo F, Scheurer S, Wangorsch A, et al.: Pyr c 1, the major alrergen from pear (Pyrus communis), is a new member of the Bet v 1 allergen family. J Chromatogr B Biomed Sci Appl 2001, 756:281-293.
50. Kazemi-Shirazi L, Pauli G, Purohit A, et al.: Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 2000, 105:116-125.
51. Moverare R, Westritschnig K, Svensson M, et al.: Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 2002, 128:325-335.
52. Valenta R, Duchene M, Pettenburger K, et al.: Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science 1991, 253:557-560.
53. Valenta R, Ferreira F, Grote M, et al.: Identification of profilin as an actin-binding protein in higher plants. J Biol Chem 1993, 268:22777-22781.
54. Seiberler S, Schemer O, Kraft D, et al.: Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins; specific expression in mature pollen and dependence of patients' IgE binding on protein-bound Ca2+. EMBO J 1994, 13:3481-3486.
55. Twardosz A, Hayek B, Seiberler S, et al.: Molecular characterization, expression in Escherichia coli and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun 1997, 239:197-204.
56. Engel E, Richter K, Obermeyer G, et al.: Immunological and biological proper-ties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 1997, 272:8630-8637.
57. Valenta R, Hayek B, Seiberler S, et al.: Calcium-binding allergens: from plants to man. Int Arch Allergy Immunol 1998, 117:160-166.
58. Karamloo F, Wangorsch A, Kasahara H, et al.: Phenylcoumaran benzylic ether and isollavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur J Biochem 2001, 268:5310-5320.
59. Cadot P, Diaz JF, Proost P, et al.: Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: Identification as a cyclophilin. J Allergy Clin Immunol 2000, 105:286-291.
60. Mahler V, Fischer S, Heiss S, et al.: cDNA cloning and characterization of a cross-reactive birch pollen allergen: identification as a pectin esterase. Int Arch Allergy Immunol 2001, 124:64-66.
61. Kazemi-Shirazi L, Niederberger V, Linhart B, et al.: Recombinant marker allergens: Diagnostic gate keepers for therapy of allergy. Int Arch Allergy Immunol 2002, 127:259-268.
62. Valenta R, Lidholm J, Niederberger V, et al.: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999, 29:896-904.
63. Hiller R, Laffer S, Harwanegg C, et al.: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002, 16:414-416.
64. Harwanegg C, Laffer S, Hiller R, et al.: Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 2003, 33:7-13.
65. Westritschnig K, Sibanda E, Thomas W, et al.: Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003, 33:22-27.
66. Ball T, Sperr WR, Valent P, et al.: Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 1999, 29:2026-2036.
67. Mothes N, Heinzkill M, Drachenberg KJ, et al.: Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted IgE production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003, 33: 1-11.
68. Moverare R, Elfman L, Vesterinen E, et al.: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002, 57:423-430.
69. van Hage-Hamsten M, Valenta R: Specific immunotherapy: the induction of new IgE-specificities? Allergy 2002, 57:375-358.
70. Valenta R: The future ofantigen-specific immunotherapy of allergy. Nat Rev Immunol 2002, 2:446-453.
71. Valenta R, Ball T, Focke M, et al.: Immunotherapy of allergic disease. Adv Immunol 2004, 82:105-153.
72. Westritschnig K, Valenta R: Can we genetically engineer safer and more effective immunotherapy reagents? Curr Opin Allergy Immunol 2003, 3:495-500.